Results 21 to 30 of about 8,519 (204)
PRMT5 links lipid metabolism to contractile function of skeletal muscles [PDF]
Skeletal muscle plays a key role in systemic energy homeostasis besides its contractile function, but what links these functions is poorly defined. Protein Arginine Methyl Transferase 5 (PRMT5) is a well-known oncoprotein but also expressed in healthy ...
Oprescu, Stephanie N +12 more
core +1 more source
PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
Protein arginine methyltransferase 5 (PRMT5), a histone methyltransferase responsible for the symmetric dimethylation of histone H4 on Arg 3 (H4R3me2s), is an enzyme that participates in tumor cell progression in a variety of hematological malignancies ...
Tian Xia +5 more
doaj +1 more source
Protein arginine methyltransferase 5 (PRMT5) catalyzes the formation of mono- or symmetric dimethylarginine residues on histones and non-histone substrates and has been demonstrated to play important roles in many biological processes.
Fangfang Dong +19 more
doaj +1 more source
Mouse peritoneal macrophages were transfected with NT or Prmt5 siRNA. Transfected cells were infected with Mtb H37Rv for 24 h and assessed for the expression of PRMT5 by immunoblotting.
Salik Miskat Borbora (9381455) +2 more
core +1 more source
Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma
Background MYC amplification or overexpression is common in Group 3 medulloblastoma and is associated with the worst prognosis. Recently, protein arginine methyl transferase (PRMT) 5 expression has been closely associated with aberrant MYC function in ...
Nagendra K. Chaturvedi +11 more
doaj +1 more source
Multiple Sclerosis (MS) is a debilitating central nervous system disorder associated with inflammatory T cells. Activation and expansion of inflammatory T cells is thought to be behind MS relapses and influence disease severity.
Stephanie A. Amici +5 more
doaj +1 more source
The Role of PRMT5 in Immuno-Oncology
Immune checkpoint inhibitor (ICI) therapy has caused a paradigm shift in cancer therapeutic strategy. However, this therapy only benefits a subset of patients. The difference in responses to ICIs is believed to be dependent on cancer type and its tumor microenvironment (TME).
Yoshinori Abe +2 more
openaire +2 more sources
2467 PRMT5 is a master epigenetic regulator to promote repair of radiation-induced DNA damage
OBJECTIVES/SPECIFIC AIMS: We recently reported that PRMT5 epigenetically activates androgen receptor (AR) in prostate cancer cells. Because targeting AR signaling through androgen deprivation therapy is clinically used as a radiosensitization approach to
Jake L. Owens
doaj +1 more source
Background As an emerging treatment strategy for triple-negative breast cancer (TNBC), immunotherapy acts in part by inducing ferroptosis. Recent studies have shown that protein arginine methyltransferase 5 (PRMT5) has distinct roles in immunotherapy ...
Jian Zhang +15 more
doaj +1 more source
Protein Arginine N-methyltransferases 5 and 7 Promote HIV-1 Production
Current therapies for human immunodeficiency virus type 1 (HIV-1) do not completely eliminate viral reservoirs in cells, such as macrophages. The HIV-1 accessory protein viral protein R (Vpr) promotes virus production in macrophages, and the maintenance ...
Hironobu Murakami +12 more
doaj +1 more source

